Doxepin Tablet
FDA Label NDC 70771-1528

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Doxepin (NDC 70771-1528). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package Label.Principal Display Panel

NDC 70771-1528-5 in bottle of 500 tablets

Doxepin Tablets, 3 mg

Rx only

500 tablets

3 mg Label (7527369f 667a 4706 B7ac 6ea6bc643e88 01)

3 mg Label (7527369f 667a 4706 B7ac 6ea6bc643e88 01)

NDC 70771-1529-5 in bottle of 500 tablets

Doxepin Tablets, 6 mg

Rx only

500 tablets

6 mg Label (7527369f 667a 4706 B7ac 6ea6bc643e88 02)

6 mg Label (7527369f 667a 4706 B7ac 6ea6bc643e88 02)

* Please review the disclaimer below.